Company news

Valerio Therapeutics news in 2025

Valerio Therapeutics's news releases, calls and decks from 2025, newest first.

View company

Valerio Therapeutics Announces the Appointment of Professor Eric Vivier as Observer to Its Board of Directors

December 17, 2025

Valerio Therapeutics announces the appointment of Eric Vivier as observer to its Board of Directors

December 15, 2025

Completion of the merger between Valerio Therapeutics and its subsidiary valour bio

December 12, 2025

Valerio Therapeutics announces changes in the composition of its Board of Directors

November 26, 2025

Cooptation d'Antonin de Fougerolles en qualité d' Administrateur de Valerio Therapeutics

November 26, 2025

Projet de fusion entre Valerio Therapeutics et sa filiale Valour Bio

October 31, 2025

Projet de fusion entre Valerio Therapeutics et sa filiale valour bio

October 31, 2025

Valerio Therapeutics: Proposed merger between Valerio Therapeutics and its subsidiary Valour Bio

October 31, 2025

Press Release Publication Half-Year Financial Report 2025

October 30, 2025

Half-Year Financial Report 2025

October 30, 2025

2025 Half-Yearly Financial Report

October 29, 2025

Valerio Therapeutics réalisation d'une augmentation de capital avec surpression du droit préférentiel de souscription

October 16, 2025

Valerio Therapeutics announces the completion of a capital increase with cancellation of preferential subscription rights

October 15, 2025

Transactions on the share capital of Valerio Therapeutics to restructure part of its liabilities

July 22, 2025

Valerio Therapeutics: Postponement of 2024 Annual Financial Report Publication and the Approval of Financial Statements

May 6, 2025

Decks in 2025